Arrhythmia Monitoring Devices Market Research Report - Forecast till 2027

Arrhythmia Monitoring Devices Market Report Information By Device Type (Resting ECG, Event Monitor, Holter Monitor, Others), Application (Tachycardia, Bradycardia, Others), End User (Hospitals and Clinics, Others) and Region - Forecast till 2027

ID: MRFR/MED/5251-CR | May 2019 | Region: Global | 134 pages

Arrhythmia Monitoring Devices Market Overview


As per the analysis conducted by Market Research Future (MRFR), the Arrhythmia monitoring devices market size is anticipated to witness a CAGR of 6.44% and is expected to amass a market value of USD 8,087.4 Million by 2024. A cardiac arrhythmia is a condition where the heartbeat is irregular, i.e., either too slow or too fast. The state is also known as cardiac dysrhythmia.


The growing usage of telecardiology and the on-going development of smart cardiac monitors are expected to be a significant factor that can grow the global arrhythmia monitoring devices market. In addition, the portability of cardiac arrhythmia monitoring devices is predicted to increase its demand that can augment the market size.


On the flip side, expenses associated with remote cardiac arrhythmia monitoring and product recalls are projected to hinder the growth of the arrhythmia monitoring devices market during the review timeframe.


COVID-19 has adversely impacted the arrhythmia monitoring devices market due to the disruption in the supply chain. Besides, the supply chain, the production process has also been affected severely. In addition, the imposition of lockdown in various lucrative markets, such as India, Italy, and others, is expected to derail the market momentum further.


Market Dynamics


Arrhythmia monitoring system has been gaining significance in recent years owing to the rising cases of heart diseases. The ease of FDA approvals, increasing adoption of low-cost electrocardiogram (ECG) devices, and the increasing geriatric population are some salient causes that can propel the industry in the coming period. In addition, the mounting cases of cardiac disorders are likely to favor market expansion in the assessment period.


 However, complications related to these devices may negatively affect the expansion of the arrhythmia monitoring devices market over the assessment period.


Drivers


Innovation in Product to Grow the Adoption of Device among Professionals


The on-going technical development allowing remote monitoring of cardiac rhythm in patients is expected to be one of the most salient factors that can augment the market in the coming period.  The high accuracy and efficiency provided by arrhythmia detection is expected to surge its demand, thereby raising the market. Furthermore, the growing requirement for continuous cardiac rhythm monitoring in the emergency department is expected to augment the arrhythmia monitoring devices market size in the assessment period.


Opportunities


Growing Incidence of CVDs to Offer Market Expansion Opportunities


Adoption of unhealthy diet such as; consumption of a sugar-rich diet, smoking, alcoholism, and higher adoption of a sedentary lifestyle are some of the crucial factors that can offer various expansion opportunities to the arrhythmia monitoring devices industry.


Restraints


Associated Complications can impede the market


Despite the propelling factors, the market can witness hindrance in the coming period. The complications related to such devices along with the rise in recalls of arrhythmia monitoring devices can bring negative impact on the arrhythmia monitoring devices market share.


Challenges


Lack of Resources can pose a Severe Challenge to Grow the Market


The market is predicted to experience a challenge due to the lack of expertise. In addition, some cardiac monitoring devices may have a negative impact on patients, which is another potent challenge that can restrict the market from growing.


Cumulative Growth Analysis


The market is projected to Show Steady Growth in the Assessment Timeframe


The market for arrhythmia monitoring devices is expected to experience a notable expansion in the coming period owing to the increasing cases of CVDs along with the expansion of geriatric population.


Market Segmentation


By Device Type


Holter Monitor Expected to Gain Prominence


Based on type, the global market for cardiac arrhythmia monitoring devices market is segmented into event monitor, resting ECG, implantable cardiac monitor (ICM), mobile cardiac telemetry (MCT) devices, Holter monitor, and others. Holter monitor is predicted to gain prominence in the coming period due to the introduction of wireless wearable technology in the device.


By Application


The Tachycardia Segment to Grow Significantly


Based on application, the global market for cardiac arrhythmia monitoring devices market is segmented into bradycardia, tachycardia, atrial fibrillation (A-fib), premature ventricular contractions (PVC), ventricular fibrillation (V-fib), conduction disorders, and others. Among all, the tachycardia segment is expected to grow significantly during the forecast period.


By End-User


Hospitals and Clinics to Dominate the Market


Based on type, the global market for cardiac arrhythmia monitoring devices market is segmented into ambulatory surgery centers (ASC), diagnostic centers, hospitals & clinics, home care settings, and others. The hospitals and clinics segment accounted for a market value of USD 1,740.0 Million in 2018.


Regional Analysis


North America is expected to dominate the Cardiac Arrhythmic Monitoring Devices Market


North America is estimated to dominate the arrhythmia monitoring devices market growth during the assessment period. The growing awareness created by several initiatives taken by governments and as well as private firms are likely to play a salient role in underpinning the market expansion. The rising collaborations between research labs and institutions is propelling the growth of the arrhythmia monitoring devices market in the region.


The European arrhythmia monitoring devices market is expected to be the second-largest market owing to the growing occurrences of cardiac disorders in the region. In Europe, Spain accounted for a market share of 5.5% in 2018.


Asia-Pacific is estimated to be the fastest-growing market owing to the developing healthcare infrastructure and increasing disposable income. The increasing geriatric population and the rising integration of the latest technologies are expected to drive the regional market. In addition, the availability of portable and home-based arrhythmia monitors are projected to play a salient role in developing the regional market in the coming period.


The Middle East and Africa is projected to experience steady expansion owing to the limited access and healthcare affordability among the population. However, the market can show significant growth due to the presence of untapped market opportunities.


Competitive Landscape


Better Distribution System to Fuel the Competition


The market leaders with sufficient funds can afford a better distribution system and efficient funds for research that is anticipated to strengthen the prevailing competition among the established key players. In addition, the emergence of small players owing to the growing awareness is expected to enhance the competitiveness of the trade further.


Industry News


November 2020: The San Francisco-based company Fitbit received approval from the US Food and Drug Administration (FDA) for its electrocardiogram (ECG) app to assess heart rhythm for atrial fibrillation.


Key Players



  • Abbott Laboratories (US)

  • BioTelemetry Inc. (US)

  • Fukuda Denshi Co. Ltd (Japan)

  • Applied Cardiac Systems Inc. (US)

  • Medtronic plc (Ireland)

  • Nihon Kohden Corporation (Japan)

  • Alive Cor Inc. (US)

  • Biotronik (Germany)

  • GE Healthcare (US)

  • Spacelabs Healthcare (US)


Report Overview


Arrhythmia Monitoring Devices Market is predicted to show significant growth in the assessment period. The arrhythmia monitoring devices market is projected to augment due to the on-going technical development in the market along with the growing awareness about the CVDs.



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2024: USD 8,087.4 Million
  • 2027: Significant Value
  •   CAGR   6.44% (2019-2024)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Device Type, Application, End User, Region
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Abbott Laboratories (US), BioTelemetry Inc. (US), Fukuda Denshi Co. Ltd (Japan), Applied Cardiac Systems Inc. (US), Medtronic plc (Ireland), Nihon Kohden Corporation (Japan), Alive Cor Inc. (US), Biotronik (Germany), GE Healthcare (US), Spacelabs Healthcare (US)
      Key Market Opportunities   Growing Incidence of CVDs to Offer Market Expansion Opportunities
      Key Market Drivers   Innovation in Product to Grow the Adoption of Device among Professionals


    Frequently Asked Questions (FAQ) :


    The arrhythmia monitoring devices market would be worth USD 8,087.4 million by 2024.

    The arrhythmia monitoring devices market is showing signs of 6.44% CAGR during the forecast period of 2020 to 2027.

    The arrhythmia monitoring devices market growth can be deterred by the high cost of the remote monitoring system and notable product recalls.

    The hospitals & clinics segment would dominate the arrhythmia monitoring devices market.

    The Americas have the chance to rule the arrhythmia monitoring devices market.